Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies to Announce Second Quarter 2025 Financial Results GlobeNewswire July 03, 2025 MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025. Given […]

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP

Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at theEmpire State Buildingin New York City and are investigating — GMS Inc. (NYSE:GMS)related to its

CUB STATEMENT ON PASSAGE OF BUDGET BILL

The budget reconciliation bill that passed today represents higher power bills for consumers in Illinois and across the country. Tax credits that help everyday people use solar power or energy efficiency to cut costs at home are wildly popular and highly successful. These incentives are cost-effective ways to cut utility bills, reduce energy prices for

ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. – OGN

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / July 3, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

AUSTIN, July 03, 2025 (GLOBE NEWSWIRE) — SECTION 1 – INTRODUCTION As interest in blood sugar health continues to expand across both clinical and non-clinical audiences, consumers are increasingly turning to nutrition science for new pathways to glucose management. Search trends show a growing curiosity in natural approaches to support healthy glucose levels, with a

Techy Acquires NerdsToGo, Expanding Its Tech Franchise Powerhouse

Strategic acquisition unites two industry leaders to create a comprehensive tech support service network. Techy, a global leader in device repair services, buyback programs, and smart device solutions, announced today the acquisition of NerdsToGo, a respected U.S.-based IT support franchise known for providing on-site and remote tech support services for homes and small businesses. https://mma.prnewswire.com/media/2724538/Techy_Logo.jpg

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support Featuring Sukre(TM) for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness GlobeNewswire July 03, 2025 AUSTIN, July 03, 2025 (GLOBE NEWSWIRE) — SECTION 1 – INTRODUCTION As interest in blood sugar health continues to expand across both clinical

Aeries Technology Announces Completion of Fiscal Year 2025 Earnings Call

(NASDAQ:AERT), NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or the “Company”), a leading partner to private-equity-backed enterprises building and scaling Global Capability Centers (“GCCs”), today announced that it held its Annual Fiscal Year 2025 Earnings and Business Update Conference Call earlier today. Chief Executive Officer Ajay Khare and Chief Financial

BioLab Holdings, Inc. Launches Multicenter Clinical Trial to Evaluate Amnion Grafts for Chronic Wounds

Study Will Assess Real-World Effectiveness of Tri-Layer and Single-Layer Amnion Grafts in Treating Diabetic Foot and Venous Leg Ulcers BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and regenerative therapies, is pleased to announce the launch of a multicenter hybrid platform trial evaluating the clinical effectiveness of its amnion-based wound care products

Aeries Technology Announces Completion of Fiscal Year 2025 Earnings Call

Aeries Technology Announces Completion of Fiscal Year 2025 Earnings Call Core Adjusted EBITDA exceeds guidance; Company re-affirms FY 2026 outlook as AI-Centric Global Capability Center strategy accelerates GlobeNewswire July 03, 2025 NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or the “Company”), a leading partner to private-equity-backed enterprises building and scaling

Scroll to Top